RVNC
Revance Therapeutics, Inc.
RVNC
RVNC
Delisted
RVNC was delisted on the 5th of February, 2025.
144 hedge funds and large institutions have $1.23B invested in Revance Therapeutics, Inc. in 2020 Q2 according to their latest regulatory filings, with 27 funds opening new positions, 64 increasing their positions, 33 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
11% more funds holding
Funds holding: 130 → 144 (+14)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
Holders
144
Holding in Top 10
2
Calls
$5.45M
Puts
$1.09M
Top Buyers
| 1 | +$30.8M | |
| 2 | +$26.6M | |
| 3 | +$14.2M | |
| 4 |
BlackRock
New York
|
+$10.5M |
| 5 |
Jennison Associates
New York
|
+$10.4M |
Top Sellers
| 1 | -$45.7M | |
| 2 | -$21M | |
| 3 | -$7M | |
| 4 |
Franklin Resources
San Mateo,
California
|
-$5.4M |
| 5 |
ACH
ArrowMark Colorado Holdings
Denver,
Colorado
|
-$5.15M |